BridgeBio Pharma (BBIO) PT Raised to $75 at BofA Securities

January 5, 2021 8:01 AM EST
Get Alerts BBIO Hot Sheet
Price: $63.74 -0.3%

Rating Summary:
    11 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 12 | New: 42
Trade Now! 
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $75.00 (from $44.00) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change